M. Flajolet

Molecular Biology · 2003–2016

A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

Whom M. Flajolet trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. P. Cohen

Who trusts M. Flajolet overall

  1. Nicolas Frémaux
  2. Michael J Frank
  3. Tiago V. Maia
  4. Wolfram Schultz
  5. Raphael Cohn
  6. D. A. Peterson
  7. V. Pawlak

Papers from M. Flajolet's perspective

Ordered by how strongly the researchers M. Flajolet trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The specificities of protein kinase inhibitors: an update. (Biochemical Journal)
  2. Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice
  3. GSK-3-selective inhibitors derived from Tyrian purple indirubins. (Chemistry and Biology)
  4. Protein kinases — the major drug targets of the twenty-first century? (Nature reviews. Drug discovery)
  5. Specificity and mechanism of action of some commonly used protein kinase inhibitors. (Biochemical Journal)
  6. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor (Nature Medicine)
  7. Protein Kinase Inhibitors: Insights into Drug Design from Structure (Science)
  8. GSK3 inhibitors: development and therapeutic potential (Nature reviews. Drug discovery)
  9. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 (Science)
  10. Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein (Journal of Neuroscience)

Their papers